Vukovic Petar G,Jeremic Aleksandra,Vezmar Milica,Milosavljevic Filip,Pavlovic Zorana Z,Pesic Danilo R,Drakulic-Djordjevic Jelena,Pejuskovic Bojana,Markovic Bojan D,Ingelman-Sundberg Magnus,Miljevic Cedo D,Maric Nadja P,Jukic Marin M (2026) Perceived stress four weeks after initiation of escitalopram monotherapy as a predictor of anxiolytic and antidepressant effects, JOURNAL OF AFFECTIVE DISORDERS, vol. 403, br. , str. - (Article) Vukovic Petar G,Jeremic Aleksandra,Vezmar Milica,Milosavljevic Filip,Pavlovic Zorana Z,Pesic Danilo R,Drakulic-Djordjevic Jelena,Pejuskovic Bojana,Markovic Bojan D,Ingelman-Sundberg Magnus,Miljevic Cedo D,Maric Nadja P,Jukic Marin M (2025) Effectiveness and safety of escitalopram treatment personalized based on therapeutic drug monitoring of drug plasma concentration: a prospective cohort study, SCIENTIFIC REPORTS, vol. 15, br. 1, str. - (Article) Manojlovic Marina,Milosavljevic Filip,Atanasov Andrea,Batinic Bojan A,Sitarica Pavle,Pesic Vesna,Jukic Marin M (2024) Social isolation during adolescence causes increased generalised anxiety-like behaviour in male rats and increased sociability in male and female rats, NEUROSCIENCE APPLIED, vol. 3, br. , str. - (Article) Vukovic Petar G,Jeremic A,Vezmar Milica,Pesic Danilo R,Pejuskovic Bojana,Drakulic-Djordjevic Jelena,Milosavljevic Filip,Miljevic Cedo D,Maric-Bojovic Nadja P,Markovic Bojan D,Ingelman Sundberg Magnus,Jukic Marin M (2024) Association between escitalopram dose personalisation based on quantification of drug plasma levels and the outcome of escitalopram treatment, EUROPEAN PSYCHIATRY, vol. 67, br. , str. S44-S45 (Meeting Abstract) Milosavljevic Filip,Manojlovic Marina,Matkovic Lena,Molden Espen,Ingelman Sundberg Magnus,Leucht Stefan,Jukic Marin M (2024) Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs, JAMA NETWORK OPEN, vol. 7, br. 8, str. - (Article) Milosavljevic Filip,Molden Espen,Ingelman Sundberg Magnus,Jukic Marin M (2024) Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trials, EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 81, br. , str. 43-52 (Review) Milosavljevic Filip,...,Atanasov Andrea,Manojlovic Marina,Vucic Marija,Orescanin-Dusic Zorana S,Brkljacic Jelena B,Miljevic Cedo D,Nikolic-Kokic Aleksandra L,Blagojevic Dusko P,...,Pesic Vesna,...,Jukic Marin M (2023) The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia, NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, vol. 49, br. 1, str. - (Article) Jukic Marin M,Milosavljevic Filip,Molden Espen,Ingelman-Sundberg Magnus (2022) Pharmacogenomics in treatment of depression and psychosis: an update, TRENDS IN PHARMACOLOGICAL SCIENCES, vol. 43, br. 12, str. 1055-1069 (Review) Jokovic Danilo B,Milosavljevic Filip,Stojanovic Zvezdana B,Supic Gordana M,Vojvodic Danilo V,Uzelac Bojana,Jukic Marin M,Petkovic-Curcin Aleksandra B (2022) CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability, PSYCHIATRY RESEARCH, vol. 312, br. , str. - (Article) Pridgeon Chris S,Bolhuis Dian P,Milosavljevic Filip,Manojlovic Marina,Vegvari Akos,Gaetani Massimiliano,Jukic Marin M,Ingelman-Sundberg Magnus (2022) Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids, CELLS, vol. 11, br. 10, str. - (Article) Milosavljevic Filip,Bukvic Nikola,Pavlovic Zorana Z,Miljevic Cedo D,Pesic Vesna,Molden Espen,Ingelman-Sundberg Magnus,Leucht Stefan,Jukic Marin M (2021) Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure A Systematic Review and Meta-analysis, JAMA PSYCHIATRY, vol. 78, br. 3, str. 270-280 (Review) Milosavljevic Filip,Bukvic Nikola,Pavlovic Zorana Z,Miljevic Cedo D,Pesic Vesna,Molden Espen,Ingelman-Sundberg Magnus,Leucht Stefan,Jukic Marin M (2020) Impact of CYP2C19 and CYP2D6 polymorphism on antidepressants and antipsychotics exposure; a meta-analysis, EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 40, br. , str. S250-S251 (Meeting Abstract) Milosavljevic Filip,Vucic Marija,Manojlovic M,Milosevski T,Batinic Bojan A,Novalen M,Miksys S,Tyndale FR,Ingelman-Sundberg Magnus,Pesic Vesna,Jukic Marin M (2020) Reduced cerebellum volume and ataxia-like motoric phenotype in transgenic mouse, carrier of human CYP2C19 gene, EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 40, br. , str. S208-S208 (Meeting Abstract) Kapor Slobodan,Aksic Milan Z,Puskas Laslo A,Jukic Marin M,Poleksic Joko Lj,Milosavljevic Filip,Bjelica Suncica,Filipovic Branislav R (2020) Long-Term Effects of Maternal Deprivation on the Volume of Dopaminergic Nuclei and Number of Dopaminergic Neurons in Substantia Nigra and Ventral Tegmental Area in Rats, FRONTIERS IN NEUROANATOMY, vol. 14, br. , str. - (Article) Milosavljevic Filip,Bukvic Nikola,Pesic Vesna,Molden Espen,Ingelman-Sundberg Magnus,Jukic Marin M (2019) Quantification of antidepressant and antipsychotic exposure increase caused by CYP2C19 and CYP2D6 intermediate and poor metabolizer status by meta-analysis, EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 29, br. , str. S533-S534 (Meeting Abstract) Milosavljevic Filip,Vucic Marija,Manojlovic M,Asujic N,Batinic Bojan A,Novalen M,Miksys S,Tyndale RF,Ingelman-Sundberg Magnus,Jukic Marin M (2019) Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia, EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 29, br. , str. S399-S400 (Meeting Abstract) Milosavljevic Filip,Vucic Marija,Manojlovic M,Asujic N,Batinic Bojan A,Novalen M,Miksys S,Tyndale RF,Ingelman-Sundberg Magnus,Pesic Vesna,Jukic Marin M (2019) Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia, EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 29, br. , str. S17-S17 (Meeting Abstract) Milosavljevic Filip,Vucic Marija,Manojlovic M,Asujic N,Batinic Bojan A,Novalen M,Miksys S,Tyndale RF,Ingelman-Sundberg Magnus,Pesic Vesna,Jukic Marin M (2019) Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia, EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 29, br. , str. S672-S673 (Meeting Abstract) Baralic Katarina V,Curcic Marijana M,Antonijevic Evica Lj,Bulat Zorica L,Jankovic Sasa D,Todorovic Milica,Milosavljevic Filip,Kotur-Stevuljevic Jelena M,Kalimanovska Vesna V,Matovic Vesna,Antonijevic Biljana,Djukic-Cosic Danijela D (2017) Obesity in relation with erythrocyte lead level in people exposed to environmental lead in Belgrade, Serbia, TOXICOLOGY LETTERS, vol. 280, br. , str. S179-S179 (Meeting Abstract)